Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-24 4:48 pm Purchase | 2026-04-17 | 13G | JATT II Acquisition Corp. JATT | Commodore Capital LP | 500,000 6.400% | 500,000 (New Position) | Filing History |
| 2026-04-02 4:26 pm Purchase | 2026-03-26 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | Commodore Capital LP | 1,950,000 9.900% | 1,820,959 (+1411.15%) | Filing History |
| 2026-03-16 4:21 pm Purchase | 2026-03-09 | 13G | AN2 THERAPEUTICS INC ANTX | Commodore Capital LP | 3,697,435 9.900% | 3,697,435 (New Position) | Filing History |
| 2026-03-11 4:06 pm Purchase | 2026-03-04 | 13G | PEPGEN INC PEPG | Commodore Capital LP | 3,544,101 5.100% | 3,544,101 (New Position) | Filing History |
| 2026-02-24 4:38 pm Purchase | 2026-02-17 | 13G | IMMUNIC INC IMUX | Commodore Capital LP | 13,350,121 9.900% | 13,350,121 (New Position) | Filing History |
| 2026-02-17 4:42 pm Sale | 2025-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,802,905 1.800% | -7,405,155 (-72.54%) | Filing History |
| 2026-02-17 4:35 pm Sale | 2025-12-31 | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | Commodore Capital LP | 0 0.000% | -750,000 (Position Closed) | Filing History |
| 2026-02-17 4:29 pm Sale | 2025-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Commodore Capital LP | 1,475,000 1.400% | -4,225,000 (-74.12%) | Filing History |
| 2026-02-17 4:26 pm Purchase | 2025-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Commodore Capital LP | 4,383,508 9.900% | 2,015,624 (+85.12%) | Filing History |
| 2026-02-17 4:22 pm Sale | 2025-12-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Commodore Capital LP | 18,851 0.300% | -332,997 (-94.64%) | Filing History |
| 2026-02-17 4:21 pm Sale | 2025-12-31 | 13G | DEFINIUM THERAPEUTICS INC DFTX | Commodore Capital LP | 7,428,775 7.200% | -747,946 (-9.15%) | Filing History |
| 2026-02-17 4:13 pm Purchase | 2025-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Commodore Capital LP | 3,245,628 9.900% | 55,361 (+1.74%) | Filing History |
| 2026-02-09 4:40 pm Purchase | 2026-02-02 | 13G | PERSPECTIVE THERAPEUTICS INC C CATX | Commodore Capital LP | 11,939,753 9.900% | 8,589,753 (+256.41%) | Filing History |
| 2026-01-16 4:23 pm Purchase | 2026-01-09 | 13G | CENTURY THERAPEUTICS INC IPSC | Commodore Capital LP | 13,043,478 7.100% | 13,043,478 (New Position) | Filing History |
| 2025-11-17 5:39 pm Purchase | 2025-11-10 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Commodore Capital LP | 5,650,000 5.100% | 5,650,000 (New Position) | Filing History |
| 2025-11-14 5:17 pm Sale | 2025-09-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Commodore Capital LP | 3,200,000 3.900% | -1,100,000 (-25.58%) | Filing History |
| 2025-11-14 5:08 pm Sale | 2025-09-30 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Commodore Capital LP | 3,028,335 4.600% | -321,665 (-9.60%) | Filing History |
| 2025-11-14 5:02 pm Sale | 2025-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | Commodore Capital LP | 3,780,055 4.900% | -69,945 (-1.82%) | Filing History |
| 2025-11-14 4:57 pm Purchase | 2025-09-30 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 10,208,060 7.200% | 3,800,000 (+59.30%) | Filing History |
| 2025-11-14 4:51 pm Purchase | 2025-09-30 | 13G | TERNS PHARMACEUTICALS INC TERN | Commodore Capital LP | 5,700,000 6.500% | 1,050,000 (+22.58%) | Filing History |